145 related articles for article (PubMed ID: 10607488)
1. Extensive surface phenotyping of alveolar macrophages in interstitial lung disease.
Taylor ML; Noble PW; White B; Wise R; Liu MC; Bochner BS
Clin Immunol; 2000 Jan; 94(1):33-41. PubMed ID: 10607488
[TBL] [Abstract][Full Text] [Related]
2. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
3. BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.
Domagała-Kulawik J
Diagn Cytopathol; 2008 Dec; 36(12):909-15. PubMed ID: 18855907
[TBL] [Abstract][Full Text] [Related]
4. Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage.
Damjanov N; Ostojic P; Kaloudi O; Alari S; Guiducci S; Stanflin N; Nestorovic B; Knezevic J; Camiciottoli G; Porta F; Pistolesi M; Ibba-Manneschi L; Conforti ML; Candelieri A; Matucci Cerinic M
Respiration; 2009; 78(1):56-62. PubMed ID: 18931474
[TBL] [Abstract][Full Text] [Related]
5. The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage.
Stríz I; Wang YM; Svarcová I; Trnka L; Sorg C; Costabel U
Eur Respir J; 1993 Oct; 6(9):1287-94. PubMed ID: 7904572
[TBL] [Abstract][Full Text] [Related]
6. [Interferon gamma (IFN-gamma) level in broncholaveolar lavage (BAL) fluid is positively correlated with CD4/CD8 ratio in selected interstitial lung diseases].
Kopiński P; Przybylski G; Jarzemska A; Sładek K; Soja J; Iwaniec T; Balicka-Slusarczyk B; Pinis G; Dyczek A; Szabłowska K; Golińska J; Jankowski M; Szczeklik J
Pol Merkur Lekarski; 2007 Jul; 23(133):15-21. PubMed ID: 18051824
[TBL] [Abstract][Full Text] [Related]
7. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
8. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease.
Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W
Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238
[TBL] [Abstract][Full Text] [Related]
9. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
[TBL] [Abstract][Full Text] [Related]
10. Role of bronchoalveolar lavage in the initial diagnosis of smoking-related interstitial lung diseases.
Domagala-Kulawik J; Maskey-Warzechowska M; Krenke R; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():243-51. PubMed ID: 19218648
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic analysis of alveolar macrophages and lymphocytes following allergen inhalation by atopic subjects with mild asthma.
Lensmar C; Katchar K; Eklund A; Grunewald J; Wahlström J
Respir Med; 2006 May; 100(5):918-25. PubMed ID: 16202577
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous presence of neutrophil alveolitis and Ki-67 positivity of alveolar macrophages in dermato-/polymyositis and systemic sclerosis.
Kumánovics G; Magyarlaki T; Komócsi A; Szekeres G; Czirják L
Rheumatol Int; 2003 Jan; 23(1):6-10. PubMed ID: 12548435
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases.
Petkova D; Xaubet A; Picado C; Filella X; Agusti C; Luburich P; Rodriguez-Roisin R
Respir Med; 2000 Apr; 94(4):345-9. PubMed ID: 10845432
[TBL] [Abstract][Full Text] [Related]
14. [Phenotype of alveolar lymphocytes--theoretical and practical implications].
Kopiński P
Przegl Lek; 2000; 57(9):493-8. PubMed ID: 11199873
[TBL] [Abstract][Full Text] [Related]
15. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease.
Morgan AJ; Guillen C; Symon FA; Huynh TT; Berry MA; Entwisle JJ; Briskin M; Pavord ID; Wardlaw AJ
Clin Exp Allergy; 2005 Dec; 35(12):1572-80. PubMed ID: 16393323
[TBL] [Abstract][Full Text] [Related]
16. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
[TBL] [Abstract][Full Text] [Related]
17. Suppressor cell activity of human alveolar macrophages in interstitial lung diseases.
Fireman EM; Ben Efraim S; Greif J; Kivity S; Topilsky MR
Clin Exp Immunol; 1988 Jul; 73(1):111-6. PubMed ID: 2971484
[TBL] [Abstract][Full Text] [Related]
18. Alveolar macrophage surface carbohydrate expression is altered in interstitial lung disease as determined by lectin-binding profiles.
Meyer KC; Powers C; Rosenthal N; Auerbach R
Am Rev Respir Dis; 1993 Nov; 148(5):1325-34. PubMed ID: 8239171
[TBL] [Abstract][Full Text] [Related]
19. Alveolar macrophage subpopulations in bronchoalveolar lavage and induced sputum of asthmatic and control subjects.
St-Laurent J; Turmel V; Boulet LP; Bissonnette E
J Asthma; 2009 Feb; 46(1):1-8. PubMed ID: 19191129
[TBL] [Abstract][Full Text] [Related]
20. Bronchoalveolar lavage in smokers: quantification of alveolar macrophages and neutrophils as markers of bronchial obstruction.
Jimenez Ruiz CA; Rajas O; Ruiz A; Ramos A; Florez S; Ramos L; Solano S; Fornies E
In Vivo; 1998; 12(4):427-30. PubMed ID: 9706495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
